Latest Innovation News

Aquirian’s Drillforce subsidiary has secured a $48 million, three-year drilling and blasting contract at Brightstar’s Lord Byron mine, marking a significant expansion of their strategic partnership in Western Australia’s Goldfields region.

Henderson Far East Income Limited posted a robust 23.3% net asset value total return for the half-year ending February 2026, supported by strong Asian tech and financial sector gains. The trust declared a 6.25p interim dividend and raised £39.1 million through new share issuance, securing a spot in the FTSE 250.

Ovanti Limited has raised $5.27 million through a discounted placement, aiming to accelerate its global Buy Now Pay Later platform and Super App development with AI integration and merchant expansion.

Marquee Resources (ASX:MQR) has secured a non-exclusive R&D patent licence with Oak Ridge National Laboratory, granting access to NEAREST technology tailored for clay-rich rare earth deposits like Redlings in WA. This partnership could reshape processing efficiency and environmental impact for Marquee’s significant inferred resource.

ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Larvotto Resources is progressing the Hillgrove Antimony-Gold Project on time and budget, aiming for mid-2026 production amid rising strategic demand for antimony. The project benefits from grid power, ongoing drilling success, and government support for critical minerals.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Elevate Uranium announces a maiden Inferred Mineral Resource of 10.1 million pounds U3O8 at Namib IV, boosting the Koppies Project resource to 76.2 Mlb and Namibia’s total uranium inventory to 106.4 Mlb. The deposit remains open for expansion amid ongoing drilling and proprietary processing developments.

AVITA Medical’s Cohealyx-I study interim results show a significant acceleration in skin grafting time for full-thickness wounds, reducing mean time to graft from 33.2 to 13.6 days. The ongoing trial’s promising data could reshape wound care protocols.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.